New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
07:08 EDTENMDEntreMed initiates Phase 2 trial in advanced/metastatic soft tissue sarcoma
EntreMed announced the initiation of a single-center Phase 2 study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Advanced/Metastatic Soft Tissue Sarcoma". The primary objective of this Phase 2 study is to evaluate the safety and efficacy of ENMD-2076 in advanced/metastatic STS patients with the 6 month PFS rate as the end point of the study.
News For ENMD From The Last 14 Days
Check below for free stories on ENMD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ENMD

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use